Literature DB >> 17132544

A pathophysiological approach to metabolic syndrome using factor analysis in an adult Romanian population.

Constantin Ionescu-Tirgoviste1, Sorin Ioacara, Cristian Guja, Sorin Sabau, Radu Lichiardopol, Andrada Mihai, Eduard Apetrei.   

Abstract

The aim of the study was to examine the role of insulin resistance in etiopathogenesis of metabolic syndrome in an adult Romanian population using exploratory factor analysis. We analyzed 228 non-diabetic subjects randomized in respect to the age and sex distribution of the general population. For each patient, age, sex, body mass index (BMI), systolic and diastolic blood pressure (SBP, DBP), HDL-cholesterol (HDL), plasma triglycerides (TG), fasting plasma glucose (FPG) and fasting insulin were obtained. Factor analysis was performed using principal component analysis, with Varimax rotation of the major determinants of metabolic syndrome. Mean age was 48.9 +/- 12.7 years; 107 (46.9%) were men and 121 (53.1%) women. We found three major factors, which are correlated with metabolic syndrome and may explain its variance. Factor 1 comprises SBP and DBP in men and SBP, DBP and BMI in women. Factor 2 comprises BMI, HDL, TG and FPG in men and BMI, TG and FPG in women. Factor 3 comprises fasting insulin in men and fasting insulin, TG and HDL in women. The finding of more than one factor suggests that insulin resistance is not the only pathophysiological mechanism involved. These factors appear to work independently of each other in men, but they intersect in women, suggesting that the pathophysiology of metabolic syndrome may be different in women compared with men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132544     DOI: 10.1080/13813450600976374

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  1 in total

1.  The sensitivity in the IR spectrum of the intact and pathological tissues by laser biophotometry.

Authors:  Cristian Ravariu; Ala Bondarciuc
Journal:  Lasers Med Sci       Date:  2013-06-08       Impact factor: 3.161

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.